kt 5823 has been researched along with gallic acid in 2 studies
| Studies (kt 5823) | Trials (kt 5823) | Recent Studies (post-2010) (kt 5823) | Studies (gallic acid) | Trials (gallic acid) | Recent Studies (post-2010) (gallic acid) |
|---|---|---|---|---|---|
| 317 | 0 | 59 | 4,793 | 42 | 2,579 |
| Protein | Taxonomy | kt 5823 (IC50) | gallic acid (IC50) |
|---|---|---|---|
| Urokinase-type plasminogen activator | Homo sapiens (human) | 6.6 | |
| Tissue-type plasminogen activator | Homo sapiens (human) | 6.6 | |
| Plasminogen activator inhibitor 1 | Homo sapiens (human) | 6.6 | |
| Urokinase-type plasminogen activator | Mus musculus (house mouse) | 6.6 | |
| 72 kDa type IV collagenase | Homo sapiens (human) | 4.03 | |
| Matrilysin | Homo sapiens (human) | 4.03 | |
| Dipeptidyl peptidase 4 | Homo sapiens (human) | 4.65 | |
| Alpha-synuclein | Homo sapiens (human) | 4.43 | |
| 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 | Homo sapiens (human) | 4.03 | |
| Polypeptide N-acetylgalactosaminyltransferase 2 | Homo sapiens (human) | 1.37 | |
| Alpha-(1,3)-fucosyltransferase 7 | Homo sapiens (human) | 4.03 | |
| CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 | Homo sapiens (human) | 4.03 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexander, JS; Battarbee, H; Gute, D; Krsmanovic, A; Okayama, N; Park, JH | 1 |
| Iida, H; Inoue, N; Ishida, H; Ishikawa, Y; Yuan, Z | 1 |
2 other study(ies) available for kt 5823 and gallic acid
| Article | Year |
|---|---|
Hypoxia/aglycemia increases endothelial permeability: role of second messengers and cytoskeleton.
Topics: Alkaloids; beta Catenin; Cadherins; Calcium; Calcium Channel Blockers; Calcium Signaling; Carbazoles; Cell Hypoxia; Cell Membrane Permeability; Cell Survival; Cells, Cultured; Cyclic GMP-Dependent Protein Kinases; Cytoskeletal Proteins; Cytoskeleton; Dermis; Endothelium; Enzyme Inhibitors; Flavonoids; Gallic Acid; Glucose; Humans; Indoles; Intercellular Junctions; Isoenzymes; Membrane Proteins; Microspheres; Mitogen-Activated Protein Kinases; Occludin; Oxygen; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-alpha; Second Messenger Systems; Thioglycolates; Trans-Activators | 1999 |
Effect of SNI-2011 on amylase secretion from parotid tissue in rats and in neuronal nitric oxide synthase knockout mice.
Topics: Alkaloids; Amylases; Animals; Azepines; Benzoates; Benzylamines; Calcium; Calcium Channel Blockers; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Carbachol; Carbazoles; Chelating Agents; Cyclic GMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Activation; Enzyme Inhibitors; Estrenes; Gallic Acid; Genotype; Guanylate Cyclase; Imidazoles; In Vitro Techniques; Indoles; Male; Mice; Mice, Knockout; Molsidomine; Muscarinic Agonists; Myosin-Light-Chain Kinase; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Oxadiazoles; Parotid Gland; Penicillamine; Phosphodiesterase Inhibitors; Pilocarpine; Protein Kinase Inhibitors; Pyrroles; Pyrrolidinones; Quinoxalines; Quinuclidines; Rats; Rats, Wistar; Sulfonamides; Thiophenes; Type C Phospholipases | 2003 |